Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2022-08-08 Director's Dealing
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
111年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors and senior management, showing their current holdings, pledged shares, and related information. It is a disclosure of insider shareholdings and pledges, typical of a Director's Dealing or insider shareholding notification. There is no indication of financial results, meeting materials, or regulatory filings beyond insider shareholding data. The document length is 2491 characters, which is relatively short but contains detailed insider shareholding data. Therefore, the best fitting category is Director's Dealing (DIRS).
2022-08-08 Chinese
111年第2季海外子公司投資
Fund Information / Factsheet Classification · 85% confidence The document is a brief financial disclosure related to investment in overseas subsidiaries, showing investment amounts, holding percentages, and recognized investment gains for a specific quarter (111年2季, which corresponds to the second quarter of the 111th year in the Taiwanese calendar). The content is tabular and concise, focusing on investment details rather than a full financial report or detailed analysis. The document length is only 662 characters, indicating it is a short summary rather than a comprehensive report. It does not contain full financial statements or extensive narrative, so it is not an Annual Report (10-K) or Interim Report (IR). It is also not an announcement of a report publication or a certification. The nature of the data aligns with a Fund Information / Factsheet (FS), which typically provides brief summaries of key financial facts and investment holdings. Therefore, the best classification is Fund Information / Factsheet (FS).
2022-08-03 Chinese
111年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment amounts, and investment income recognized for the period. The document is short (1287 characters) and primarily provides regulatory-required investment information rather than a full financial report or announcement. It does not contain comprehensive financial statements or management discussion, nor is it an announcement of a report publication. This type of disclosure is typical of a Regulatory Filing (RNS) as it provides compliance-related investment data without constituting a full report or announcement.
2022-08-03 Chinese
公告本公司董事會通過111年第二季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1786 科妍) reporting the board's approval of the consolidated financial report for the second quarter of the year 111 (Taiwan calendar, equivalent to 2022). It includes cumulative financial data from January 1 to June 30, such as revenue, gross profit, operating profit, net profit, EPS, total assets, liabilities, and equity. The document is short (896 characters) and appears to be a formal announcement of the board's approval of the interim financial report rather than the full report itself. It does not contain detailed financial statements or extensive analysis, but summary financial figures. Given the nature of the content and the reporting period (half-year), this fits the definition of an Interim / Quarterly Report (IR). The document is not merely announcing the report's publication but provides substantive financial data, so it is not an RPA or RNS. Therefore, the classification is IR with high confidence. H1 2022
2022-08-03 Chinese
111年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated statement of changes in equity for the first half of the year 2022 (民國111年上半年度), with detailed financial data such as share capital, capital surplus, legal reserve, special reserve, undistributed earnings, and total equity. The presence of actual financial figures and the focus on a half-year period indicate this is a financial report for a period shorter than a full fiscal year. The document length is 3084 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-03 Chinese
111年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the second quarter of the fiscal year 111 (which corresponds to 2022 in the Taiwanese calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 2249 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or certification. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2022
2022-08-03 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.